Murine RAW 264.7 cell line as an immune target: are we missing something?

Liza Merly, Sylvia L. Smith

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The popular murine macrophage cell line, RAW 264.7, is often used to initially screen natural products for bioactivity and to predict their potential effect in vivo or on primary cells. The cell line response is considered to reflect the potential human de novo response, and is used to evaluate the effective bioactivity of the product. Here, we compared the cytokine response of RAW 264.7 cells to shark cartilage (SC) with that of human leukocytes to determine whether the cell line response was a reliable predictor of the cytokine response one can expect from similarly stimulated human primary cells. Results not only revealed significant differences in the nature and level of TNFα produced by cells in vitro, but also showed that while the primary cell response included an upregulation in the production of IL-1β such a response was absent in RAW 264.7 cells. This suggests that had we relied on RAW 264.7 cells alone to assess the cytokine-inducing capacity of SC, the comprehensive Th1 response (shown in an earlier study) induced by SC in primary cells, consisting of release of several proinflammatory cytokines and chemokines, would not have been revealed. We conclude, therefore, that assays using only RAW 264.7 cells to initially screen for and assess immune reactivity of test products will not necessarily provide a comprehensive picture of the immunomodulatory properties of the substance under investigation, and can in fact be misleading with regard to the overall bioactive potential of the substance on an initial screen.

Original languageEnglish (US)
Pages (from-to)55-58
Number of pages4
JournalImmunopharmacology and Immunotoxicology
Volume39
Issue number2
DOIs
StatePublished - Mar 4 2017

Fingerprint

Cartilage
Sharks
Cells
Cytokines
Bioactivity
Macrophages
Cell Line
Biological Products
Interleukin-1
Chemokines
Assays
Leukocytes
Up-Regulation
RAW 264.7 Cells

Keywords

  • Cytokine response
  • human leukocytes
  • murine cell line
  • shark cartilage

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Toxicology
  • Pharmacology

Cite this

Murine RAW 264.7 cell line as an immune target : are we missing something? / Merly, Liza; Smith, Sylvia L.

In: Immunopharmacology and Immunotoxicology, Vol. 39, No. 2, 04.03.2017, p. 55-58.

Research output: Contribution to journalArticle

@article{f24aa15653984beaa4b2afe155e21548,
title = "Murine RAW 264.7 cell line as an immune target: are we missing something?",
abstract = "The popular murine macrophage cell line, RAW 264.7, is often used to initially screen natural products for bioactivity and to predict their potential effect in vivo or on primary cells. The cell line response is considered to reflect the potential human de novo response, and is used to evaluate the effective bioactivity of the product. Here, we compared the cytokine response of RAW 264.7 cells to shark cartilage (SC) with that of human leukocytes to determine whether the cell line response was a reliable predictor of the cytokine response one can expect from similarly stimulated human primary cells. Results not only revealed significant differences in the nature and level of TNFα produced by cells in vitro, but also showed that while the primary cell response included an upregulation in the production of IL-1β such a response was absent in RAW 264.7 cells. This suggests that had we relied on RAW 264.7 cells alone to assess the cytokine-inducing capacity of SC, the comprehensive Th1 response (shown in an earlier study) induced by SC in primary cells, consisting of release of several proinflammatory cytokines and chemokines, would not have been revealed. We conclude, therefore, that assays using only RAW 264.7 cells to initially screen for and assess immune reactivity of test products will not necessarily provide a comprehensive picture of the immunomodulatory properties of the substance under investigation, and can in fact be misleading with regard to the overall bioactive potential of the substance on an initial screen.",
keywords = "Cytokine response, human leukocytes, murine cell line, shark cartilage",
author = "Liza Merly and Smith, {Sylvia L.}",
year = "2017",
month = "3",
day = "4",
doi = "10.1080/08923973.2017.1282511",
language = "English (US)",
volume = "39",
pages = "55--58",
journal = "Immunopharmacology and Immunotoxicology",
issn = "0892-3973",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Murine RAW 264.7 cell line as an immune target

T2 - are we missing something?

AU - Merly, Liza

AU - Smith, Sylvia L.

PY - 2017/3/4

Y1 - 2017/3/4

N2 - The popular murine macrophage cell line, RAW 264.7, is often used to initially screen natural products for bioactivity and to predict their potential effect in vivo or on primary cells. The cell line response is considered to reflect the potential human de novo response, and is used to evaluate the effective bioactivity of the product. Here, we compared the cytokine response of RAW 264.7 cells to shark cartilage (SC) with that of human leukocytes to determine whether the cell line response was a reliable predictor of the cytokine response one can expect from similarly stimulated human primary cells. Results not only revealed significant differences in the nature and level of TNFα produced by cells in vitro, but also showed that while the primary cell response included an upregulation in the production of IL-1β such a response was absent in RAW 264.7 cells. This suggests that had we relied on RAW 264.7 cells alone to assess the cytokine-inducing capacity of SC, the comprehensive Th1 response (shown in an earlier study) induced by SC in primary cells, consisting of release of several proinflammatory cytokines and chemokines, would not have been revealed. We conclude, therefore, that assays using only RAW 264.7 cells to initially screen for and assess immune reactivity of test products will not necessarily provide a comprehensive picture of the immunomodulatory properties of the substance under investigation, and can in fact be misleading with regard to the overall bioactive potential of the substance on an initial screen.

AB - The popular murine macrophage cell line, RAW 264.7, is often used to initially screen natural products for bioactivity and to predict their potential effect in vivo or on primary cells. The cell line response is considered to reflect the potential human de novo response, and is used to evaluate the effective bioactivity of the product. Here, we compared the cytokine response of RAW 264.7 cells to shark cartilage (SC) with that of human leukocytes to determine whether the cell line response was a reliable predictor of the cytokine response one can expect from similarly stimulated human primary cells. Results not only revealed significant differences in the nature and level of TNFα produced by cells in vitro, but also showed that while the primary cell response included an upregulation in the production of IL-1β such a response was absent in RAW 264.7 cells. This suggests that had we relied on RAW 264.7 cells alone to assess the cytokine-inducing capacity of SC, the comprehensive Th1 response (shown in an earlier study) induced by SC in primary cells, consisting of release of several proinflammatory cytokines and chemokines, would not have been revealed. We conclude, therefore, that assays using only RAW 264.7 cells to initially screen for and assess immune reactivity of test products will not necessarily provide a comprehensive picture of the immunomodulatory properties of the substance under investigation, and can in fact be misleading with regard to the overall bioactive potential of the substance on an initial screen.

KW - Cytokine response

KW - human leukocytes

KW - murine cell line

KW - shark cartilage

UR - http://www.scopus.com/inward/record.url?scp=85011579822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011579822&partnerID=8YFLogxK

U2 - 10.1080/08923973.2017.1282511

DO - 10.1080/08923973.2017.1282511

M3 - Article

C2 - 28152640

AN - SCOPUS:85011579822

VL - 39

SP - 55

EP - 58

JO - Immunopharmacology and Immunotoxicology

JF - Immunopharmacology and Immunotoxicology

SN - 0892-3973

IS - 2

ER -